Associated chief physician, Zhongnan Hospital of Wuhan University, China
Fan Lin, MD, PhD, is an associate professor and transplant surgeon at Zhongnan Hospital of Wuhan University, affiliated with the Institute of Hepatobiliary Diseases and the Transplant Center of Wuhan University. He also serves as an expert with the National Quality Control Center for Donated Organ Procurement of China. With over a decade of experience in surgery, he has significantly contributed to advancements in liver transplantation, particularly in the area of steatotic liver grafts. Fan is recognized internationally for his interdisciplinary research and innovative work, particularly in organ preservation techniques, benefiting both clinical practice and scientific progress in transplantation. He is committed to improving organ quality and recovery through novel machine perfusion systems and has collaborated with diverse scientific teams to further his research goals. 🌍🩺
Profile
Scopus
Education
Fan Lin obtained his MD and PhD degrees from Wuhan University. He completed his Doctorate in Surgery under the guidance of Prof. Ye Qifa between 2014 and 2017, where he focused on liver transplantation and perfusion systems. Before his doctoral studies, he completed his Master’s degree in Surgery at Wuhan University from 2012 to 2014, also advised by Prof. Ye Qifa. His academic training laid a strong foundation for his future research in transplantation science, specifically targeting organ preservation and regeneration. 📚🎓
Experience
Dr. Fan Lin has held pivotal roles in the medical field, starting as a resident doctor in the Transplant Center of Zhongnan Hospital of Wuhan University in 2017. He was seconded to the National Health Commission of China from 2017 to 2018 before returning to Zhongnan Hospital as an attending physician in the Transplant Center, where he continued to develop his expertise in transplant surgery. From 2020 to 2021, he also served as Deputy Chief of Medical Services at Zhongnan Hospital. Currently, he holds the position of associate chief physician and associate professor at Zhongnan Hospital, where he continues to lead research and surgical advancements in liver transplantation. 🏥💉
Awards and Honors
Fan Lin has received numerous accolades, including the prestigious “Anti-Epidemic Star” title from Zhongnan Hospital in 2020. He was recognized as one of the “Young Medical Talents” in the same year and received multiple Science and Technology Progress Awards, including the First Prize of Hubei Province in 2019. His research excellence and academic contributions were also acknowledged by Wuhan University, awarding him Outstanding Graduate titles over multiple years (2012-2017). These honors underscore his significant contributions to the field of transplant surgery and medical research. 🏅🏆
Research Focus
Dr. Fan Lin’s research focuses on improving the quality of donor organs, particularly liver grafts, through advanced preservation techniques such as hypothermic oxygenated machine perfusion (HOPE). His doctoral research explored the protective effects of HOPE on steatotic livers and the underlying molecular mechanisms. Additionally, he has conducted interdisciplinary research on nerve regeneration in collaboration with the College of Chemistry and Molecular Sciences at Wuhan University. His studies aim to enhance the functional recovery of organs, paving the way for better outcomes in organ transplantation. 🧬🔬
Publications
- “A Novel Machine Perfusion System for Enhancing Hepatic Microcirculation Perfusion” (2024) 🧑🔬
- “Hypothermic Oxygenated Perfusion (HOPE) with Defatting Cocktail Further Improves Steatotic Liver Grafts in a Transplantation Rat Model” (2021) 💉
- “Polyaniline Promotes Peripheral Nerve Regeneration by Enhancement of BDNF and CNTF Expression” (2017) 🔬
- “Double-Lobectomy in a Steatotic Liver Transplantation Rat Model” (2021) 🐀
- “Cytochrome b5 Interacts With Cytochrome C and Inhibits Hepatocyte Apoptosis in Brain-Dead Rabbit Donors” (2019) 🧬
- “Hypothermic Oxygenated Machine Perfusion Alleviates Donation After Circulatory Death Liver Injury” (2019) 💔
- “Arsenic Trioxide is an Immune Adjuvant in Liver Cancer Treatment” (2017) 🧪
- “Peroxiredoxin 6 Attenuates Ischemia- and Hypoxia-Induced Liver Damage of Brain-Dead Donors” (2016) 🧠